- RAPS, Wednesday, August 13, 2014 11:43 AM
The US Food and Drug Administration (FDA) doesn’t like brands -- or at least those under its purview -- “liking” unapproved claims on Facebook. In one case, as the Regulatory Affairs
Professional Society reports, the FDA reprimanded a supplement marketer for “liking” customer claims that its products could cure cancer. Now, RAPS suggests that the FDA is setting its
sights on similar activity on Twitter.
Read the whole story at RAPS »
